Category: alexknappblog

InnovationRx: Science Slowdown, A New Covid Variant Surges And Helping Chemo Patients Keep Their Hair

InnovationRx is your weekly digest of healthcare news. Sign up!

InnovationRx: Moderna’s Cancer Vaccine, Undercounted Covid Deaths And Sergey Brin’s Fight Against Parkinson’s

InnovationRx is your weekly digest of healthcare news. Sign up!

InnovationRx: Healthcare’s Power Women, China Loosens Covid Rules And A Boost For Value-Based Care

InnovationRx is your weekly digest of healthcare news. Sign up!

This Company Just Raised $140 Million To Accelerate Patient-Oriented, Value-Based Primary Care

Since settling into the role, the company has seen tremendous growth.

Forbes Under 30 Healthcare 2023: Fighting Cancer, Expanding Access To Care And Protecting Women’s Health

These scientists and entrepreneurs are taking on some of healthcare’s biggest challenges, from cancer to women’s health to ensuring equitable access to care.

This Biotech Entrepreneur Just Raised $10 Million To Develop A Universal Flu Vaccine

Distributed Bio cofounder Jacob Glanville’s new venture, Centivax, just raised a seed round to lay a foundation for human trials of its promising vaccine platform.

This Entrepreneur Aims To Make Cognitive Screening As Easy As Checking Your Pulse

Elli Kaplan’s company Neurotrack says it’s developed a cognitive screening test that can be done in just three minutes.

This Company Just Raised $71 Million To See The Forest For The Trees Within A Patient’s Cells

Spatial biology startup Resolve Biosciences is building up capital to accelerate its development of ‘Genomics 3.0.’

Move Over, Elon: This Under 30 CEO Just Raised $8 Million To Build A Next-Generation Brain Implant

Paul Le Floch’s company, Axoft, is developing brain implants made from soft, flexible materials that reduce injury and could treat disorders such as cerebral palsy.

Billionaire Scientist Timothy Springer Awarded 2022 Lasker Prize For Basic Research

The award, which he shares with two others, is for a set of discoveries in the 1970s that form the basis for new drug treatments today.